Most recently, it has been recognized that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions to be a scavenger and does not a